Stockreport

Legend Biotech Corporation (NASDAQ:LEGN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think [Yahoo! Finance]

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF The early response was not positive, with shares down 2.6% to US$39.89 in the past week. The results don't look great, especially considering that statutory losses grew [Read more]